Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: Membrane Filtration Method Optimization – V 2.0

Posted on By

Analytical Method Development: Membrane Filtration Method Optimization – V 2.0

Standard Operating Procedure for Membrane Filtration Method Optimization in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/129/2025
Supersedes SOP/AMD/129/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP outlines the procedure for optimizing membrane filtration techniques used for microbiological and chemical analysis in pharmaceutical products, ensuring filtration efficiency, analyte recovery, and regulatory compliance.

2. Scope

This procedure

applies to the Analytical Method Development (AMD) department and microbiological laboratories involved in sample preparation and microbial enumeration using membrane filtration techniques for water, APIs, and dosage forms.

3. Responsibilities

  • Microbiologist: Conducts filtration, monitors flow rate, and assesses recovery performance.
  • Analytical Scientist: Coordinates validation of membrane compatibility and analyte retention.
  • QA Officer: Verifies method optimization steps and validates all logs and records.
  • Head – AMD: Approves final optimization protocol and ensures suitability across applications.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring the optimized filtration method is robust, validated, and integrated into analytical testing programs.

See also  Analytical Method Development: SOP for Dissolution Method for Delayed Release Tablets - V 2.0

5. Procedure

5.1 Selection of Membrane Type

  1. Choose 0.45 µm cellulose nitrate or mixed cellulose ester (MCE) membrane filters for microbial analysis.
  2. Use 0.2 µm PTFE or PVDF membranes for sterilizing filtration of chemical analytes.
  3. Assess filter diameter (usually 47 mm or 90 mm) based on sample load and application.
  4. Record membrane specifications in Annexure-1: Membrane Selection Log.

5.2 Equipment Setup and Sanitization

  1. Sanitize filtration units (manifold, holders, funnels) with 70% IPA and UV exposure before use.
  2. Assemble filtration apparatus in a laminar airflow (LAF) cabinet to maintain aseptic conditions.
  3. Ensure proper sealing of membrane on base supports to avoid bypass leakage.

5.3 Filtration Procedure

  1. Filter a known volume (typically 100 mL) of the sample through the membrane using vacuum filtration.
  2. Rinse membrane with 100 mL of sterile 0.1% peptone water or buffer (if required for neutralization).
  3. For microbiological testing, transfer membrane to:
    • TSA for bacterial enumeration
    • SDA for fungal enumeration
  4. For chemical analysis, collect filtrate and test for analyte retention or loss.
  5. Log filtration details in Annexure-2: Filtration Record Sheet.
See also  Analytical Method Development: Titrimetric Assay Development for Alkalinity - V 2.0

5.4 Optimization Parameters

  1. Evaluate flow rate: Acceptable range is 20–100 mL/min depending on viscosity and pore size.
  2. Validate microbial recovery using standard spiked solutions:
    • Recovery should be 50%–200% for microbial cultures (e.g., E. coli, S. aureus)
  3. For chemical tests, assess analyte recovery by comparing pre- and post-filtration concentrations.
  4. Record findings in Annexure-3: Recovery Validation Log.

5.5 Acceptance Criteria

  1. Filtration must be complete within 10 minutes for 100 mL of aqueous samples.
  2. No clogging or channeling of membranes should be observed.
  3. Recovery rates should meet the acceptance range as defined in the validation protocol.

5.6 Documentation and Final Report

  1. Summarize results including flow rates, membrane integrity, and analyte recovery.
  2. Include graphs or photographs as applicable (e.g., microbial growth on membranes).
  3. Compile and approve optimization protocol in Annexure-4: Method Optimization Summary.

6. Abbreviations

  • MCE: Mixed Cellulose Ester
  • PVDF: Polyvinylidene Difluoride
  • PTFE: Polytetrafluoroethylene
  • LAF: Laminar Airflow
  • CFU: Colony Forming Units
  • SOP: Standard Operating Procedure

7. Documents

  1. Membrane Selection Log – Annexure-1
  2. Filtration Record Sheet – Annexure-2
  3. Recovery Validation Log – Annexure-3
  4. Method Optimization Summary – Annexure-4
See also  Analytical Method Development: Gas Evolution Reaction Method - V 2.0

8. References

  • USP <61> – Microbial Enumeration
  • USP <1227> – Validation of Microbial Recovery
  • ICH Q2(R1) – Validation of Analytical Procedures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Membrane Selection Log

Membrane Type Pore Size Diameter Application Selected By
MCE 0.45 µm 47 mm Microbial Enumeration Sunita Reddy

Annexure-2: Filtration Record Sheet

Sample ID Volume Filter Type Start Time End Time
FIL-129-01 100 mL MCE 0.45 µm 10:00 AM 10:06 AM

Annexure-3: Recovery Validation Log

Organism/Analyte Pre-Filtration Value Post-Filtration Value % Recovery Status
E. coli 95 CFU 88 CFU 92.6% Pass

Annexure-4: Method Optimization Summary

Membrane filtration method optimized using MCE 0.45 µm membranes. Recovery validated for E. coli, S. aureus, and P. aeruginosa. Flow rate and recovery met acceptance criteria. Method ready for routine use and validation.

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Incorporated chemical compatibility and flow rate benchmarks Annual SOP Review
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Cleaning and Maintenance of HEPA Filters in Cleanrooms – V 2.0
Next Post: Gel Manufacturing: SOP for Conducting Supplier Audits for Raw Materials – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version